registrieren | anmelden | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

catcremonas cancer [70 articles]

Neue Publikationen in catcremonas Bibliothek eingetragen unter dem Bezeichner: cancer. You can also see everyone's cancer.
  • Mechanisms to control rereplication and implications for cancer.
    Current opinion in cell biology, Vol. 19, No. 6. (December 2007), pp. 663-671.
    by SS Hook, JJ Lin, A Dutta
    posted to review rereplication instability genomic cancer by catcremona on 2008-11-26 14:58:49 as **
  • gammaH2AX and cancer.
    Nature reviews. Cancer (13 November 2008)
    by William M M Bonner, Christophe E E Redon, Jennifer S S Dickey, Asako J J Nakamura, Olga A A Sedelnikova, Stéphanie Solier, Yves Pommier
    posted to review h2ax cancer by catcremona on 2008-11-24 14:05:57 as **
  • Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
    Nature Reviews Cancer, Vol. 8, No. 10. (11 September 2008), pp. 755-768.
    by Jane E Visvader, Geoffrey J Lindeman
  • Genomic instability--the engine of tumorigenesis?
    Nature reviews. Cancer, Vol. 3, No. 9. (September 2003), pp. 701-708.
    posted to instability genomic chromosome cancer by catcremona on 2008-10-10 17:14:45 as **
  • Aneuploidy and cancer
    Nature, Vol. 432, No. 7015. (18 November 2004), pp. 338-341.
    by Harith Rajagopalan, Christoph Lengauer
  • On the road to cancer: aneuploidy and the mitotic checkpoint
    Nature Reviews Cancer, Vol. 5, No. 10. (01 October 2005), pp. 773-785.
    by Geert JPL Kops, Beth AA Weaver, Don W Cleveland
  • Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials.
    Accounts of chemical research, Vol. 36, No. 6. (June 2003), pp. 417-425.
    by L Meijer, E Raymond
    posted to roscovitine inhibitor cdk cancer by catcremona on 2008-10-03 18:00:48 as **
  • A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
    British Journal of Cancer, Vol. aop, No. current. (19 December 2006)
    posted to inhibitor cdk cancer by catcremona on 2008-10-03 17:56:14 as **
  • CDK inhibitors in cancer therapy: what is next?
    Trends in pharmacological sciences, Vol. 29, No. 1. (January 2008), pp. 16-21.
    posted to inhibitor cdk cancer by catcremona on 2008-10-03 17:53:57 as **
  • CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases
    Oncogene, Vol. aop, No. current.
    posted to roscovitine inhibitor cdk cancer by catcremona on 2008-10-03 17:51:18 as **
  • Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Cancer research, Vol. 58, No. 3. (1 February 1998), pp. 542-548.
    posted to prostate p27 cancer by catcremona on 2008-10-03 17:33:56 as **
  • Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis.
    Cancer, Vol. 103, No. 5. (1 March 2005), pp. 952-959.
    by E Massarelli, E Brown, NK Tran, DD Liu, JG Izzo, JJ Lee, AK El-Naggar, WK Hong, VA Papadimitrakopoulou
    posted to p27 cancer by catcremona on 2008-10-03 17:31:45 as **
  • Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
    Nat Med, Vol. 8, No. 10. (October 2002), pp. 1136-1144.
    by Giuseppe Viglietto, Maria L Motti, Paola Bruni, Rosa M Melillo, Amelia D'Alessio, Daniela Califano, Floriana Vinci, Gennaro Chiappetta, Philip Tsichlis, Alfonso Bellacosa, Alfredo Fusco, Massimo Santoro
    posted to p27 localization cancer by catcremona on 2008-10-03 17:29:20 as **
  • Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability
    Mol. Cell. Biol., Vol. 28, No. 20. (15 October 2008), pp. 6223-6233.
    by Elizabeth S Mckenna, Courtney G Sansam, Yoon-Jae Cho, Heidi Greulich, Julia A Evans, Christopher S Thom, Lisa A Moreau, Jaclyn A Biegel, Scott L Pomeroy, Charles W Roberts
    posted to snf5 instability genomic epigenetic chromatin cancer by catcremona on 2008-10-01 09:34:27 as **
  • Replication licensing and cancer — a fatal entanglement?
    Nature Reviews Cancer, Vol. 8, No. 10. (29 August 2008), pp. 799-806.
    by Julian J Blow, Peter J Gillespie
    posted to replication mcm licensing geminin dna cancer by catcremona on 2008-09-25 14:53:23 as **
  • Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
    The Journal of urology, Vol. 170, No. 1. (July 2003), pp. 241-245.
    posted to skp2 prostate p27 cancer by catcremona on 2008-09-22 11:26:33 as **
  • p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.
    Experimental cell research, Vol. 264, No. 1. (10 March 2001), pp. 148-168.
    posted to p27 expression degradation cancer by catcremona on 2008-09-22 11:23:35 as **
  • p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.
    Journal of the National Cancer Institute, Vol. 98, No. 23. (6 December 2006), pp. 1723-1731.
    by PL Porter, WE Barlow, IT Yeh, MG Lin, XP Yuan, E Donato, GW Sledge, CL Shapiro, JN Ingle, CM Haskell, KS Albain, JM Roberts, RB Livingston, DF Hayes
    posted to survival p27 cancer by catcremona on 2008-09-22 11:19:44 as **
  • Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition.
    Cancer cell, Vol. 14, No. 1. (8 July 2008), pp. 23-35.
    posted to proteasome p27 degradation cancer argyrin apoptosis by catcremona on 2008-09-22 11:17:22 as **
  • Molecular footprints of human lung cancer progression.
    Cancer science, Vol. 95, No. 3. (March 2004), pp. 197-204.
    by J Yokota, T Kohno
    posted to rb ras p53 lung human cancer by catcremona on 2008-09-17 13:11:11 as **
  • A genetically defined model for human ovarian cancer.
    Cancer research, Vol. 64, No. 5. (1 March 2004), pp. 1655-1663.
    by J Liu, G Yang, JA Thompson-Lanza, A Glassman, K Hayes, A Patterson, RT Marquez, N Auersperg, Y Yu, WC Hahn, GB Mills, RC Bast
    posted to rb ras p53 ovarian human cancer by catcremona on 2008-09-17 13:09:29 as **
  • Bladder cancer. I. Molecular and genetic basis of carcinogenesis.
    European urology, Vol. 39, No. 5. (May 2001), pp. 491-497.
    by S Brandau, A Böhle
    posted to rb ras p53 human cancer bladder by catcremona on 2008-09-17 13:05:07 as **
  • A genetically tractable model of human glioma formation.
    Cancer research, Vol. 61, No. 9. (1 May 2001), pp. 3556-3560.
    by JN Rich, C Guo, RE McLendon, DD Bigner, XF Wang, CM Counter
    posted to rb ras p53 human glioma cancer by catcremona on 2008-09-17 13:03:27 as **
  • Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Molecular and cellular biology, Vol. 21, No. 6. (March 2001), pp. 2144-2153.
    by N Bardeesy, BC Bastian, A Hezel, D Pinkel, RA DePinho, L Chin
    posted to rb ras p53 melanoma cancer by catcremona on 2008-09-17 13:01:07 as **
  • Expression of ras Rb1 and p53 proteins in human breast cancer.
    Anticancer research, Vol. 12, No. 1. (b 1992), pp. 81-89.
    posted to rb ras p53 human cancer breast by catcremona on 2008-09-17 12:54:49 as **
  • Genetic modeling of Ras-induced human rhabdomyosarcoma.
    Methods in enzymology, Vol. 438 (2008), pp. 419-427.
    by CM Linardic, CM Counter
    posted to tumour sarcoma rb ras p53 human cancer by catcremona on 2008-09-17 12:51:27 as **
  • Proliferation of cancer cells despite CDK2 inhibition.
    Cancer cell, Vol. 3, No. 3. (March 2003), pp. 233-245.
    posted to roscovitine inhibition cellcycle cdk2 cancer by catcremona on 2008-09-12 19:36:10 as **
  • Tumor-suppressive Pathways in Pancreatic Carcinoma
    Cancer Res, Vol. 57, No. 9. (1 May 1997), pp. 1731-1734.
    by Ester Rozenblum, Mieke Schutte, Michael Goggins, Stephan A Hahn, Shawn Panzer, Marianna Zahurak, Steven N Goodman, Taylor A Sohn, Ralph H Hruban, Charles J Yeo, Scott E Kern
    posted to ras pancreatic p53 p16 cancer by catcremona on 2008-09-09 18:36:23 as **
  • Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.
    Genes & development, Vol. 17, No. 24. (15 December 2003), pp. 3112-3126.
    by AJ Aguirre, N Bardeesy, M Sinha, L Lopez, DA Tuveson, J Horner, MS Redston, RA DePinho
    posted to ras pancreatic p16 cancer by catcremona on 2008-09-09 18:18:12 as **
  • Systemic spread is an early step in breast cancer.
    Cancer cell, Vol. 13, No. 1. (January 2008), pp. 58-68.
    posted to metastasis cancer breast by catcremona on 2008-09-03 19:29:34 as **
  • ERK activation and nuclear signaling induced by the loss of cell/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells.
    Journal of cellular biochemistry (22 August 2008)
    by Adnan Al-Ayoubi, Adel Tarcsafalvi, Hui Zheng, Wayne Sakati, Scott T T Eblen
    posted to ovarian erk cancer anchorage adhesion by catcremona on 2008-09-03 11:01:01 as **
  • Skp2 Overexpression Is a Prognostic Factor in Patients with Ovarian Adenocarcinoma
    Clin Cancer Res, Vol. 9, No. 5. (1 May 2003), pp. 1756-1763.
    by Kazushi Shigemasa, Lijun Gu, Timothy J O'Brien, Koso Ohama
    posted to cancer ovarian skp2 by catcremona on 2008-07-22 14:03:52 as **
  • Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
    International journal of oncology, Vol. 25, No. 1. (July 2004), pp. 87-95.
    by JQ Li, F Wu, T Masaki, A Kubo, J Fujita, DA Dixon, RD Beauchamp, T Ishida, S Kuriyama, K Imaida
    posted to cancer colorectal skp2 by catcremona on 2008-07-22 13:29:48 as **
  • Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
    Oncology, Vol. 65, No. 4. (2003), pp. 355-362.
    by S Shintani, C Li, M Mihara, S Hino, K Nakashiro, H Hamakawa
    posted to cancer oral p27 skp2 by catcremona on 2008-07-22 13:27:00 as **
  • High Expression of S-Phase Kinase-interacting Protein 2, Human F-box Protein, Correlates with Poor Prognosis in Oral Squamous Cell Carcinomas
    Cancer Res, Vol. 61, No. 19. (1 October 2001), pp. 7044-7047.
    by Yasusei Kudo, Shojiro Kitajima, Sunao Sato, Mutsumi Miyauchi, Ikuko Ogawa, Takashi Takata
    posted to cancer oral skp2 by catcremona on 2008-07-22 13:25:48 as **
  • Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
    J Clin Invest, Vol. 110, No. 5. (September 2002), pp. 633-641.
    posted to breast cancer skp2 by catcremona on 2008-07-22 12:43:41 as ** along with 1 person jfr
  • Elevated Skp2 Protein Expression in Human Prostate Cancer: Association with Loss of the Cyclin-dependent Kinase Inhibitor p27 and PTEN and with Reduced Recurrence-free Survival
    Clin Cancer Res, Vol. 8, No. 11. (1 November 2002), pp. 3419-3426.
    by Guang Yang, Gustavo Ayala, Angelo D Marzo, Weihua Tian, Anna Frolov, Thomas M Wheeler, Timothy C Thompson, Wade J Harper
    posted to cancer p27 prostate pten skp2 by catcremona on 2008-07-22 12:40:27 as **
  • Skp2 Overexpression Is Highly Representative of Intrinsic Biological Aggressiveness and Independently Associated with Poor Prognosis in Primary Localized Myxofibrosarcomas
    Clin Cancer Res, Vol. 12, No. 2. (15 January 2006), pp. 487-498.
    by Hsuan-Ying Huang, Hong-Yo Kang, Chien-Feng Li, Hock-Liew Eng, Shih-Cheng Chou, Ching-Nan Lin, Ching-Yeh Hsiung
    posted to cancer skp2 by catcremona on 2008-07-22 00:08:56 as **
  • A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells.
    Oncogene, Vol. 14, No. 19. (15 May 1997), pp. 2283-2289.
    by C Craig, R Wersto, M Kim, E Ohri, Z Li, D Katayose, SJ Lee, J Trepel, K Cowan, P Seth
    posted to arrest cancer cdk cyclin p27 by catcremona on 2008-07-21 22:14:48 as **
  • The retinoblastoma protein pathway in cell cycle control and cancer.
    Experimental cell research, Vol. 237, No. 1. (25 November 1997), pp. 1-6.
    by J Bartek, J Bartkova, J Lukas
    posted to cancer cellcycle rb review by catcremona on 2008-07-21 20:35:14 as **
  • Cyclin E in normal and neoplastic cell cycles.
    Oncogene, Vol. 24, No. 17. (18 April 2005), pp. 2776-2786.
    by HC Hwang, BE Clurman
    posted to cancer cycline review by catcremona on 2008-05-27 23:26:18 as **
  • The hallmarks of cancer.
    Cell, Vol. 100, No. 1. (7 January 2000), pp. 57-70.
    by D Hanahan, RA Weinberg
  • A reciprocal relationship between Rb and Skp2: implications for restriction point control, signal transduction to the cell cycle and cancer.
    Cell cycle (Georgetown, Tex.), Vol. 7, No. 1. (January 2008), pp. 24-27.
    by RK Assoian, Y Yung
    posted to cancer cell cycle feedback loop rb skp2 by catcremona on 2008-05-27 21:17:29 as **
  • Limiting the proliferation of polyploid cells.
    Cell, Vol. 131, No. 3. (2 November 2007), pp. 437-440.
    by NJ Ganem, D Pellman
    posted to cancer instability polyploid tetraploid by catcremona on 2008-05-27 20:55:30 as **
  • The impact of a negligent G2/M checkpoint on genomic instability and cancer induction
    Nature Reviews Cancer, Vol. 7, No. 11., pp. 861-869.
    by Markus Löbrich, Penny A Jeggo
  • Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity.
    Cancer research, Vol. 66, No. 4. (15 February 2006), pp. 2162-2172.
    by FY Wu, SE Wang, ME Sanders, I Shin, F Rojo, J Baselga, CL Arteaga
    posted to cancer localization motility p27 sirna survival by catcremona on 2008-05-27 20:51:27 as **
  • Tensional homeostasis and the malignant phenotype.
    Cancer cell, Vol. 8, No. 3. (September 2005), pp. 241-254.
    posted to cancer cytoskeleton erk integrin rho tension by catcremona on 2008-05-27 20:26:44 as **
  • A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
    Oncogene, Vol. 18, No. 16. (22 April 1999), pp. 2579-2588.
    posted to cancer farnesyl mice nude pancreatic ras by catcremona on 2008-05-27 20:25:02 as **
  • Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
    Cancer research, Vol. 67, No. 15. (1 August 2007), pp. 7184-7193.
    by X Wang, M Zheng, G Liu, W Xia, PJ McKeown-Longo, MC Hung, J Zhao
    posted to cancer emt fak invasion klf8 by catcremona on 2008-05-27 20:21:33 as ** along with 1 person jyuh
  • Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation.
    Differentiation; research in biological diversity, Vol. 70, No. 9-10. (December 2002), pp. 547-560.
    by DE Ingber
    posted to cancer ecm emt matrix review by catcremona on 2008-05-27 19:48:21 as **
  • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/user/catcremona/tag/cancer

    Result page: 1 2 Next RIS BibTeX